Immunology and Microbiology
T Cell
100%
Cancer Cell
64%
CD47
46%
Cancer Immunotherapy
36%
CD20
35%
B Cell
35%
Bispecific Antibody
30%
TNF related apoptosis inducing ligand
28%
Ecalectin
27%
Monospecific Antibody
27%
Phagocytosis
26%
Macrophage
25%
Rituximab
25%
Tumor Necrosis Factor
24%
Cell Surface
23%
Antineoplastic Activity
22%
Cell Death
22%
T Cell Receptor
18%
Cytotoxic T-Cell
18%
Inflammatory Arthritis
17%
Calreticulin
17%
Cytotoxicity
16%
Granulocyte
16%
Tumor Cell
15%
Immunotherapy
15%
Tumor Necrosis Factor Receptor
13%
Neutrophil
13%
Immune Response
13%
Agonist
13%
CD8
12%
Cell Phagocytosis
11%
Tumor-Infiltrating Lymphocytes
11%
Myeloid
11%
CXCL16
10%
Atezolizumab
10%
Cetuximab
10%
Neutrophil Granulocyte
10%
Lymphocyte
10%
Autoimmunity
10%
Epidermal Growth Factor
9%
Tumor Immunity
9%
CD40 Ligand
9%
Surface Property
8%
Cell Line
8%
Cross Linking
8%
Endoplasmic reticulum
8%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
8%
Normal Human
8%
Antibody-Dependent Cell-Mediated Cytotoxicity
7%
Overall Survival
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
94%
Malignant Neoplasm
79%
Fusion Protein
77%
Elimination
36%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
29%
Epidermal Growth Factor Receptor
28%
Acute Myeloid Leukemia
23%
Nanoparticle
22%
Immunotherapy
21%
Rituximab
17%
Tumor Necrosis Factor
16%
Ovary Cancer
16%
Proteinase
16%
Bispecific Antibody
15%
Leukemia
13%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
12%
Single Chain Fragment Variable Antibody
12%
Melanoma
12%
Death Receptor
11%
Sodium Valproate
11%
Ecalectin
10%
Cytarabine
10%
Gemtuzumab Ozogamicin
10%
Calcium Carbonate
10%
Monoclonal Antibody
10%
Proteochondroitin Sulfate
9%
Receptor
9%
Drug Delivery System
9%
Trastuzumab
8%
CD40 Ligand
7%
T Cell Leukemia
7%
6 Diazo 5 Oxonorleucine
7%
Enzyme-Linked Immunosorbent Assay
7%
Side Effect
7%
Mouse
6%
Cytotoxicity
6%
Daratumumab
6%
Histone Deacetylase Inhibitor
6%
Clinical Trial
6%
Gamma Urogastrone
6%
Rheumatoid Arthritis
6%
Fas Ligand
6%
Controlled Release
6%
Epithelial Cell Adhesion Molecule
6%
Sodium Chloride
6%
Cytotoxicity
5%
Tissue Injury
5%
Glioblastoma
5%
Acute Lymphoblastic Leukemia
5%
Antibodies
5%
Medicine and Dentistry
T Cell
47%
Cancer Cell
43%
Fusion Protein
42%
Malignant Neoplasm
39%
Programmed Cell Death
36%
Antineoplastic Activity
31%
Neoplasm
30%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
25%
Cell Surface
24%
Calreticulin
17%
Cancer Immunotherapy
16%
Ovarian Cancer
16%
Rituximab
16%
Tumor Cell
16%
Proteinase
16%
Cancer Therapy
14%
Phagocytosis
14%
Bispecific Antibody
13%
Epidermal Growth Factor Receptor
12%
Diffuse Large B-Cell Lymphoma
12%
Target Cell
10%
Autophagy
10%
Macrophage
10%
Cell Death
10%
CD20
10%
Neutrophil
9%
In Vitro
9%
Endoplasmic reticulum
8%
Tumor Immunity
8%
Nodular Melanoma
8%
Autoimmunity
8%
Monoclonal Antibody
8%
Tumor Infiltrating Lymphocyte
8%
Lymphocyte
7%
Leukemia Cell
7%
Acute Myeloid Leukemia
7%
Single Chain Fragment Variable Antibody
7%
Tumor Necrosis Factor
7%
Overall Survival
7%
Granulocyte
7%
Antibody Dependent Cellular Cytotoxicity
7%
Cytotoxicity
7%
Immune Checkpoint Blockade
6%
Tumor Necrosis Factor Receptor
6%
Fas Ligand
6%
Immune Response
6%
CD8 Antigen
6%
Krukenberg Tumor
6%
Adult T-Cell Leukemia/Lymphoma
6%
Chimeric Antigen Receptor T-Cell
6%
